C vs IMA · P/E 16, rev $85.22B vs rev $9.2M
Citigroup Inc. (C) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
C currently screens at market cap $214.73B and trailing P/E 15.5. IMA currently screens at market cap $64.7M.
Not investment advice. Open the C and IMA stock pages for the full models.
Not investment advice.